TEE
Tibra Equities Europe Portfolio holdings
AUM
$90.4M
1-Year Return
37.81%
This Quarter Return
+6.01%
1 Year Return
+37.81%
3 Year Return
+142.95%
5 Year Return
–
10 Year Return
–
AUM
$1.35B
AUM Growth
+$350M
(+35%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
24.39%
Top 10 Holdings %
Top 10 Hldgs %
38.14%
Holding
538
New
164
Increased
22
Reduced
43
Closed
309
Top Buys
| 1 |
Technology Select Sector SPDR Fund
XLK
|
+$124M |
| 2 |
Apple
AAPL
|
+$68.9M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$58.9M |
| 4 |
The Communication Services Select Sector SPDR Fund
XLC
|
+$46.9M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$42.7M |
Top Sells
| 1 |
Walmart
WMT
|
+$49.9M |
| 2 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$49.4M |
| 3 |
Union Pacific
UNP
|
+$38.5M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$30.7M |
| 5 |
Automatic Data Processing
ADP
|
+$26.4M |
Sector Composition
| 1 | Technology | 22.36% |
| 2 | Financials | 8.27% |
| 3 | Consumer Discretionary | 7.77% |
| 4 | Industrials | 7.16% |
| 5 | Communication Services | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
MongoDB
MDB
$26.4B
| – | – |
-18,639
| Closed | -$2.74M |
|
327
MEI Pharma
MEIP
$92.3M
| – | – |
-7,605
| Closed | -$467K |
|
328
MetLife
MET
$53B
| – | – |
-60,600
| Closed | -$2.58M |
|
329
Magna International
MGA
$12.9B
| – | – |
-15,800
| Closed | -$769K |
|
330
Magnite
MGNI
$3.54B
| – | – |
-88,190
| Closed | -$536K |
|
331
Magnolia Oil & Gas
MGY
$4.39B
| – | – |
-228,769
| Closed | -$2.75M |
|
332
Moog
MOG.A
$6.05B
| – | – |
-22,400
| Closed | -$1.95M |
|
333
Marathon Petroleum
MPC
$56.5B
| – | – |
-33,300
| Closed | -$1.99M |
|
334
Mercury Systems
MRCY
$4.06B
| – | – |
-34,200
| Closed | -$2.19M |
|
335
Merck
MRK
$211B
| – | – |
-101,446
| Closed | -$8.05M |
|
336
Matinas BioPharma
MTNB
$9.44M
| – | – |
-4,839
| Closed | -$264K |
|
337
Northrop Grumman
NOC
$82.5B
| – | – |
-24,700
| Closed | -$6.66M |
|
338
Nutrien
NTR
$27.7B
| – | – |
-22,800
| Closed | -$1.2M |
|
339
Orion
OEC
$584M
| – | – |
-132,062
| Closed | -$2.51M |
|
340
Omeros
OMER
$284M
| – | – |
-44,400
| Closed | -$771K |
|
341
OptimizeRx
OPRX
$339M
| – | – |
-26,602
| Closed | -$338K |
|
342
Organogenesis Holdings
ORGO
$613M
| – | – |
-46,366
| Closed | -$348K |
|
343
Prestige Consumer Healthcare
PBH
$3.22B
| – | – |
-22,700
| Closed | -$679K |
|
344
Pacira BioSciences
PCRX
$1.2B
| – | – |
-15,200
| Closed | -$579K |
|
345
Pebblebrook Hotel Trust
PEB
$1.36B
| – | – |
-11,900
| Closed | -$370K |
|
346
Pfizer
PFE
$141B
| – | – |
-208,376
| Closed | -$8.4M |
|
347
Premier
PINC
$2.2B
| – | – |
-19,200
| Closed | -$662K |
|
348
PNC Financial Services
PNC
$80.1B
| – | – |
-12,600
| Closed | -$1.55M |
|
349
Protagonist Therapeutics
PTGX
$3.46B
| – | – |
-32,647
| Closed | -$410K |
|
350
QuinStreet
QNST
$926M
| – | – |
-16,500
| Closed | -$221K |
|